C0473: Prevention of Thromboembolic Events? European Registry in Venous Thromboembolism - Design of the Prefer in VTE

A. Cohen; Rupert Bauersachs; A. K. Gitt; Petra Laeis; Patrick Mismetti; M. Monreal; Stefan N. Willich; Giancarlo Agnelli

doi:10.1016/s0049-3848(14)50383-0

Related publications

Article2014

Readmittance To Hospital Within 6 Months After A Venous Thromboembolism Event: Prefer In Vte Registry

Rupert Bauersachs, A. K. Gitt, Patrick Mismetti, Manuel Monreal, SN Willich, Will Wolf, Giancarlo Agnelli, A. Cohen

Article2014

Treatment Satisfaction In Patients With Venous Thromboembolism As Measured With Pact-Q2: Prefer In Vte Registry

SN Willich, Rupert Bauersachs, Anselm K. Gitt, Patrick Mismetti, Manuel Monreal, Will Wolf, Giancarlo Agnelli, Alexander T. Cohen

Article2017

The role of heparin lead-in in the real-world management of acute venous thromboembolism: The PREFER in VTE registry

Rupert Bauersachs, Giancarlo Agnelli, Anselm K. Gitt, Manuel Monréal, Patrick Mismetti, Stefan N. Willich, Petra Laeis, Eva‐Maria Fronk, Peter Bramlage, Alexander T. Cohen

Article2007

Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality.

Alexander T. Cohen, Giancarlo Agnelli, Frederick A. Anderson, Juan I. Arcelus, David Bergqvist, Josef Georg Brecht, Ian A. Greer, John A. Heit, Julia Hutchinson, Ajay K. Kakkar, Dominique Mottier, Emmanuel Oger, M Samama, Michael Spannagl

Article2019

P3850Impact of sex and risk factors for venous thromboembolism on the clinical course of first acute venous thromboembolism. Insights from the PREFER in VTE

Michela Giustozzi, Stefano Barco, Luca Valerio, Frederikus A. Klok, Maria Cristina Vedovati, Cecilia Becattini, Stavros Konstantinides, Giancarlo Agnelli